Skip to main content

Table 1 Patient characteristics for MS patients with RT

From: Clinicopathologic features and responses to radiotherapy of myeloid sarcoma

Patient no. Age Gender Underlying disease GS site for radiotherapy Timing of GS emergence Cytogenetics
1 62 F AML-M2 Skin Relapse after chemotherapy, BM also (+) Normal
2 50 M CML Anus CML in blast crisis 47 XXY, inv(11)
3 83 M AML-M4 Skin Found at initial presentation with BM (+) t(2;14), NPM(-), FLT3(-)
4 55 M AML-M1 Spinal cord Relapse after chemotherapy, BM also (+) t(9;22) Philadelphia chromosome (+)
5 58 M AML-M1 Skin (7 lesions) Relapse after BMT, BM also (+) Normal
6 6 F CML Bone (right femur) CML in blast crisis t(9;22) Philadelphia chromosome (+)
7 71 F MDS- RAEB 2 Brain - Normal
8 41 F AML-M2 Cervix Relapse after BMT, BM (-) t(8;21)
     Right breast Relapse after BMT, BM (-)  
9 42 M de novo sarcoma Right nipple Found at presentation, BM (-) Normal
     Brain Relapse after chemotherapy, BM also (+)  
     Paranasosinus Relapse after chemotherapy, BM also (+)  
10 56 M CML Spinal cord CML in blast crisis Normal
11 22 M AML-M4 Skin (11 lesions) Relapse after BMT, BM (-) del(1)(p32p36), t(10;11)(p13;q13)
12 44 F CML Right breast CML in blast crisis receiving BMT. relapse after BMT, BM (-) Normal
13 75 F AML-M2 Skin Found at initial presentation with BM (+) del(15)(q22q35)
14 29 F AML-M2 Pituitary gland Relapse after BMT, BM (-) Normal
15 32 F AML-M1 Right breast Relapse after BMT, BM (-) Normal
     Left breast Relapse after BMT, BM (-)  
16 47 M AML-M1 Brain Relapse after chemotherapy, BM also (+) Normal
     Spinal cord Relapse after chemotherapy, BM also (+)  
17 47 F AML-M2 Skin Relapse after chemotherapy, BM also (+) t(8;21)
18 40 M AML-M5 Skin Emerging during chemotherapy and persistent after BMT, BM (+) -3p,t(5;17)(q15;q22), t(11;19)(q23;p13),-17,19p; der(19)t(17;19)(q11;p11), t(11;12)(p15;q13), NPM(-), FLT3(-)
19 42 F AML-M1 Right inguinal area Found at initial presentation with BM (+) Normal
20 4 M AML-M2 Bone (left tibia) Relapse after BMT, BM also (+) t(8;21), AML1-ETO fusion transcription (+)
     Left buccal mucosa Relapse after BMT, BM also (+)  
     Bone (right foot) Relapse after BMT, BM also (+)  
  1. Abbreviations: AML = acute myeloid leukemia; BM = bone marrow; BMT = bone marrow transplant; CML = chronic myeloid leukemia; FLT3 = FMS-like tyrosine kinase 3; MDS = myelodysplastic syndrome; NPM = nucleophosmin; RAEB = refractory anemia with excess blasts.